For two decades, CitiusTech refused to become a general-purpose IT shop. That stubborn focus built a valuable healthcare specialist - and now gives it a credible shot at making enterprise AI survive contact with clinical reality.
Most clinical AI is trying to write the note. RhythmX AI wants to decide what deserves the doctor's attention next - and its merger with Get Well reveals why distribution may matter as much as the model.
The Kansas company stripped the markers and force plates out of a biomechanics lab. Now it is selling clinics and performance teams a faster way to turn ordinary movement into longitudinal evidence - with useful limits that buyers should understand.
Flare Capital has nearly $1 billion under management. Its sharper pitch is a network that turns healthcare's guarded buyers into advisers, pilot partners and customers.
Teladoc made the video visit ordinary. Now it is attempting the harder trick: turning urgent care, therapy, chronic-condition coaching and hospital technology into one accountable system of care.